Related Experiment Video
Updated: Nov 19, 2025

Bioprospecting of Extremophilic Microorganisms to Address Environmental Pollution
Published on: December 30, 2021
Effluent decontamination by the ibuprofen-mineralizing strain, Sphingopyxis granuli RW412: Metabolic processes
Inés Aguilar-Romero1, Jesús De la Torre-Zúñiga1, José Miguel Quesada1
1Dept. of Environmental Protection, Estación Experimental Del Zaidín - CSIC, Calle Professor Albareda 1, 18008, Granada, Spain.
A novel bacterial strain, Sphingopyxis granuli RW412, effectively degrades ibuprofen, a common pharmaceutical pollutant. This discovery offers a sustainable solution for removing ibuprofen from wastewater treatment systems and protecting aquatic environments.
Area of Science:
- Environmental Microbiology
- Bioremediation
- Pharmaceutical Pollution Control
Background:
- Ibuprofen is a widely used pharmaceutical pollutant detected in aquatic systems due to incomplete removal by conventional wastewater treatment plants (WWTPs).
- The environmental and public health risks associated with emerging contaminants like ibuprofen necessitate advanced treatment technologies.
- Biopurification systems utilizing contaminant-degrading bacteria offer a sustainable and cost-effective approach for water decontamination.
Purpose of the Study:
- To isolate, characterize, and evaluate an ibuprofen-mineralizing bacterial strain for its efficacy in remediating ibuprofen-polluted environments.
- To elucidate the genetic and enzymatic pathways involved in ibuprofen biodegradation by the identified bacterial strain.
- To assess the strain's performance in various matrices, including laboratory media, biopurification systems, and real WWTP effluent.
Main Methods:
- Isolation and identification of ibuprofen-degrading bacteria from environmental samples (River Elbe sediments).
- Genomic analysis of the isolated strain (RW412, identified as Sphingopyxis granuli) to identify key biodegradation genes (ipf genes).
- Enzymatic assays to confirm the function of ipf genes in ibuprofen mineralization pathway.
- Microbial degradation experiments in liquid cultures, biopurification systems, and spiked WWTP effluent.
Main Results:
- Strain RW412 (Sphingopyxis granuli) possesses a 4.48 Mb genome with plasmids containing ipf genes responsible for initiating ibuprofen mineralization.
- The identified enzymes catalyze CoA ligation, aromatic ring activation, and retroaldol cleavage, producing intermediates for further degradation.
- Strain RW412 efficiently eliminated over 2 mM ibuprofen in 74 hours in lab conditions and rapidly remediated repeated doses in biopurification systems.
- The strain prevented metabolite accumulation and demonstrated a 7-fold faster ibuprofen removal rate in WWTP effluent compared to indigenous microbiota.
Conclusions:
- Sphingopyxis granuli RW412 is a robust bacterium capable of effectively mineralizing ibuprofen under diverse conditions.
- The identified ipf genes and their encoded enzymes provide a mechanistic understanding of ibuprofen biodegradation.
- This bacterial strain represents a promising bio-augmentation tool for enhancing ibuprofen removal efficiency in urban wastewater treatment systems, mitigating environmental contamination.
More Related Videos
09:49Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
15:19Development of Sulfidogenic Sludge from Marine Sediments and Trichloroethylene Reduction in an Upflow Anaerobic Sludge Blanket Reactor
Published on: October 15, 2015
Related Concept Videos
Bioremediation
Environmental Applications of Microorganisms